ARID5B	O
as	O
a	O
critical	O
downstream	O
target	O
of	O
the	O
TAL1	O
complex	O
that	O
activates	O
the	O
oncogenic	O
transcriptional	O
program	O
and	O
promotes	O
T	O
-	O
cell	O
leukemogenesis	O
.	O


The	O
oncogenic	O
transcription	O
factor	O
TAL1	O
/	O
SCL	O
induces	O
an	O
aberrant	O
transcriptional	O
program	O
in	O
T	O
-	O
cell	O
acute	O
lymphoblastic	O
leukemia	O
(	O
T	O
-	O
ALL	O
)	O
cells	O
.	O


However	O
,	O
the	O
critical	O
factors	O
that	O
are	O
directly	O
activated	O
by	O
TAL1	O
and	O
contribute	O
to	O
T	O
-	O
ALL	O
pathogenesis	O
are	O
largely	O
unknown	O
.	O


Here	O
,	O
we	O
identified	O
AT	O
-	O
rich	O
interactive	O
domain	O
5B	O
(	O
ARID5B	O
)	O
as	O
a	O
collaborating	O
oncogenic	O
factor	O
involved	O
in	O
the	O
transcriptional	O
program	O
in	O
T	O
-	O
ALL	O
.	O


ARID5B	O
expression	O
is	O
down	O
-	O
regulated	O
at	O
the	O
double	O
-	O
negative	O
2	O
-	O
4	O
stages	O
in	O
normal	O
thymocytes	O
,	O
while	O
it	O
is	O
induced	O
by	O
the	O
TAL1	O
complex	O
in	O
human	O
T	O
-	O
ALL	O
cells	O
.	O


The	O
enhancer	O
located	O
135	O
kb	O
upstream	O
of	O
the	O
ARID5B	O
gene	O
locus	O
is	O
activated	O
under	O
a	O
superenhancer	O
in	O
T	O
-	O
ALL	O
cells	O
but	O
not	O
in	O
normal	O
T	O
cells	O
.	O


Notably	O
,	O
ARID5B	O
-	O
bound	O
regions	O
are	O
associated	O
predominantly	O
with	O
active	O
transcription	O
.	O


ARID5B	O
and	O
TAL1	O
frequently	O
co	O
-	O
occupy	O
target	O
genes	O
and	O
coordinately	O
control	O
their	O
expression	O
.	O


ARID5B	O
positively	O
regulates	O
the	O
expression	O
of	O
TAL1	O
and	O
its	O
regulatory	O
partners	O
.	O


ARID5B	O
also	O
activates	O
the	O
expression	O
of	O
the	O
oncogene	O
MYC	O
Importantly	O
,	O
ARID5B	O
is	O
required	O
for	O
the	O
survival	O
and	O
growth	O
of	O
T	O
-	O
ALL	O
cells	O
,	O
and	O
forced	O
expression	O
of	O
ARID5B	O
in	O
immature	O
thymocytes	O
results	O
in	O
thymus	O
retention	O
,	O
differentiation	O
arrest	O
,	O
radioresistance	O
,	O
and	O
tumor	O
formation	O
in	O
zebrafish	O
.	O


Our	O
results	O
indicate	O
that	O
ARID5B	O
reinforces	O
the	O
oncogenic	O
transcriptional	O
program	O
by	O
positively	O
regulating	O
the	O
TAL1	O
-	O
induced	O
regulatory	O
circuit	O
and	O
MYC	O
in	O
T	O
-	O
ALL	O
,	O
thereby	O
contributing	O
to	O
T	O
-	O
cell	O
leukemogenesis	O
.	O
